Paul Russo

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari et al. · Nature Genetics · 2019 · 4.2K citations · Full text

Cancer Immunosurveillance, Tumor Heterogeneity, Medicine +9

Guideline for Management of the Clinical T1 Renal Mass

Steven C. Campbell, Andrew C. Novick, Arie S. Belldegrun et al. · The Journal of Urology · 2009 · 1.8K citations

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study

William C. Huang, Andrew S. Levey, Angel M. Serio et al. · The Lancet Oncology · 2006 · 1.6K citations · Full text

Retrospective Cohort Study, Urology, Renal Disease +12

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2002 · 1.5K citations

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer et al. · Genome biology · 2016 · 1K citations · Full text